Advertisement

Topics

Is ASCO Sending Mixed Messages On Cancer Drug Value?

08:42 EDT 13 Jun 2018 | Forbes

Endorsing a framework that incorporates cost and value implies that all relevant stakeholders, not just oncologists and their patients, would be included in the design of framework criteria that are intended to inform decisions on which drugs to develop, market, prescribe, and reimburse.

Original Article: Is ASCO Sending Mixed Messages On Cancer Drug Value?

NEXT ARTICLE

More From BioPortfolio on "Is ASCO Sending Mixed Messages On Cancer Drug Value?"

Advertisement
Quick Search
Advertisement
Advertisement